Showing results (431-440 of 623) with videos related to
Sort By:
Pageof 63
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2025
SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass CharacterizationSteven P Rowe, Brian M Shuch, Mark W Ball, et al.Plos One|December 2, 2021
Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial resultsNils Martin Bruckmann, Julian Kirchner, Janna Morawitz, et al.Cancers|July 2, 2021
Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor DecodingLale Umutlu, Julian Kirchner, Nils Martin Bruckmann, et al.EJNMMI Research|October 31, 2018
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancerKatharina Lückerath, Liu Wei, Wolfgang P Fendler, et al.American Journal of Nuclear Medicine and Molecular Imaging|January 1, 2014
Molecular imaging for early prediction of response to Sorafenib treatment in sarcomaZhoulei Li, Ken Herrmann, Sabine Pirsig, et al.Clinical Nuclear Medicine|March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CTChristina Bluemel, Markus Krebs, Bülent Polat, et al.Theranostics|May 23, 2017
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachRudolf A Werner, Alexander Weich, Takahiro Higuchi, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2021
68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular CarcinomaNader Hirmas, Catherine Leyh, Miriam Sraieb, et al.Leukemia|October 14, 2022
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trialRobert Seifert, David Kersting, Christoph Rischpler, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2025
Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET/CT During [177Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate CancerLoïc Djaileb, Andrea Farolfi, Isabel Rauscher, et al.Pageof 63